In summary, our study showed that genetically-influenced lower TG via APOA5 have additional beneficial effects on CAD risk and lipoprotein profile, which were independent from and comparable to the effects of genetically-influenced lower TG via LPL alleles. Here, APOA5 is linked to coronary artery disorder.